The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksROL.L Regulatory News (ROL)

  • There is currently no data for ROL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Rotala PLC

21 Sep 2023 16:15

RNS Number : 2690N
Royal Bank of Canada
21 September 2023
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

 

Royal Bank of Canada

 

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

RBC Trust Company (International) Limited

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

Rotala PLC

 

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

N/a

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

 

19th September 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

 

NO

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

1,216,805

 

 

3.92

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

 

1,216,805

 

 

3.92

 

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

N/a

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/a

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/a

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/a

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/a

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

21/09/2023

Contact name:

Graham Horsnell

Telephone number*:

01534 283292

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETUAAVROSUKUAR
Date   Source Headline
20th May 202011:54 amRNSAnnual Financial Report
4th May 202011:55 amRNSDirector/PDMR Shareholding
27th Apr 20208:45 amRNSDirector/PDMR Shareholding
22nd Apr 20207:00 amRNSFinal Results
9th Apr 20207:00 amRNSTrading Statement
27th Jan 20207:00 amRNSTrading Statement
2nd Jan 202010:55 amRNSDirector/PDMR Shareholding
22nd Oct 20197:00 amRNSDirector/PDMR Shareholding
18th Oct 20199:37 amRNSShare Subscription and Director Dealing
7th Oct 20192:52 pmRNSHolding(s) in Company
2nd Oct 20192:47 pmRNSIssue of Equity
22nd Aug 20197:00 amRNSHalf-year Report
21st Aug 201912:35 pmRNSSubscription of Ordinary Shares
12th Aug 20191:42 pmRNSCompletion of Acquisition
6th Aug 20191:54 pmRNSHolding(s) in Company
2nd Aug 201912:24 pmRNSDirector/PDMR Shareholding
1st Aug 20197:00 amRNSPlacing and Subscription
27th Jun 20197:00 amRNSAcquisition in Manchester
29th May 20194:57 pmRNSResult of AGM
7th May 20197:00 amRNSAnnual Financial Report
2nd Apr 20197:00 amRNSFinal Results
23rd Jan 20197:00 amRNSPre-close trading statement
2nd Jan 20194:03 pmRNSDirector/PDMR Shareholding
30th Nov 20187:00 amRNSSale of Freehold Depot and Fuel Hedging update
1st Nov 20181:54 pmRNSHolding(s) in Company
1st Nov 20181:50 pmRNSDirector/PDMR Shareholding
28th Aug 20184:09 pmRNSDirector/PDMR Shareholding
9th Aug 20187:00 amRNSHalf-year Report
20th Jul 201811:30 amRNSHolding(s) in Company
29th May 20185:00 pmRNSResult of AGM
4th May 201810:41 amRNSPosting of Annual Report and Notice of AGM
1st May 201812:10 pmRNSHolding(s) in Company
30th Apr 20182:49 pmRNSDirector/PDMR Shareholding
30th Apr 20182:46 pmRNSDirector/PDMR Shareholding
24th Apr 20185:42 pmRNSDirector/PDMR Shareholding
19th Apr 20186:20 pmRNSDirector/PDMR Shareholding
12th Apr 20185:55 pmRNSDirector/PDMR Shareholding
12th Apr 20187:00 amRNSFinal Results
23rd Feb 20184:44 pmRNSHolding(s) in Company
22nd Feb 201812:48 pmRNSHolding(s) in Company
2nd Feb 20187:00 amRNSPre-close trading statement
19th Dec 20174:29 pmRNSHolding(s) in Company
27th Nov 20177:00 amRNSCompletion of Acquisition
17th Oct 20172:30 pmRNSAcquisition
1st Sep 20173:56 pmRNSCompletion of Acquisition
25th Aug 201710:55 amRNSFurther re. Fund Raise and Acquisitions
22nd Aug 201711:47 amRNSHolding(s) in Company
18th Aug 201712:50 pmRNSResult of General Meeting and Issue of Equity
11th Aug 20177:00 amRNSDirectorate Change
11th Aug 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.